Мальта - английский - Medicines Authority

ebewe pharma gmbh nfg. kg mondseestrasse 11, 4866 unterach, austria - docetaxel - concentrate for solution for infusion - docetaxel 10 mg/ml - antineoplastic agents

Мальта - английский - Medicines Authority

ebewe pharma gmbh nfg. kg mondseestrasse 11, 4866 unterach, austria - docetaxel - concentrate for solution for infusion - docetaxel 10 mg/ml - antineoplastic agents

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - gemcitabin hcl gemcitabin hcl gemcitabin hcl - concentrate for soln for inf - 10

Армения - английский - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

ebewe pharma ges. m.b.h. nfg. kg - carboplatin - concentrate for solution for infusion - 10mg/ml

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - cisplatin 1 mg/ml - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml excipient: hydrochloric acid sodium chloride water for injection - cisplatin ebewe is indicated as palliative therapy to be employed as follows: metastatic non-seminomatous germ cell carcinoma: in established combination therapy with other approved chemotherapeutic agents in patients with metastatic non-seminomatous germ cell tumours who have already received appropriate surgical and/or radiotherapeutic procedures. metastatic ovarian tumours: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumours refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. advanced and refractory carcinoma of the bladder: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with advanced stage bladder cancer refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. squamous cell carcinoma of the head and neck (refractory to standard chemotherapy): cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with squamous cell carcinoma of the head and neck refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy.

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - carboplatin - concentrate for soln for inf - 10 mg/ml

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - gemcitabin hcl gemcitabin hcl gemcitabin hcl - concentrate for soln for inf - 10 micromol

Ирландия - английский - HPRA (Health Products Regulatory Authority)

fannin limited - vinorelbine - concentrate for soln for inf - 10 mg/ml - vinca alkaloids and analogues

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - cisplatin - solution for infusion - 1mg/1ml

Ирландия - английский - HPRA (Health Products Regulatory Authority)

ebewe pharma ges.m.b.h nfg. kg - cisplatin - concentrate for soln for inf - 0.5